The ELR device combines the convenience of an external patch with the advanced capabilities of a Holter, ensuring accurate and insightful data for the monitoring period. It has been designed and manufactured in India by CDL and is powered by a first-of-its-kind connected platform for managing tests, data, algorithms, analysis, review, and reporting. CDL\u2019s innovation includes wearables designed for use in sweat-inducing conditions with dependable workflows and minimal interventions for the use of devices. An automated data transfer mechanism allows physicians and technicians to access real-time test management dashboards and full disclosures on-demand.<\/p>\n
Cardiovascular disease (CVD) continues to be the leading cause of death globally and in India. A study by Global Burden of Disease puts the death due to CVD in India at 272 per 1 Lakh population as compared to the global average of 235.1<\/sup><\/p>\n \u201cWe are thrilled to collaborate with Medtronic in our combined objective to alleviate the burden of heart rhythm disorders in India,\u201d said Anand Madanagopal, Proven with over two million hours of ECG from patients, CDL\u2019s proprietary algorithms have been benchmarked against the best globally and remain core to their innovation and commitment to high standards of performance.2 <\/sup>This combined with the integrated platform assures test outcomes and accuracy in rhythm diagnosis.<\/p>\n \u201cCardiac rhythm disorders\u00a0can often exhibit\u00a0subtle\u00a0symptoms\u00a0and can affect people of all ages\u00a0and backgrounds. Affordable diagnostic\u00a0solutions\u00a0ensure\u00a0that everyone, regardless of their\u00a0socioeconomic\u00a0status, can access\u00a0essential diagnostic tools, leading to earlier detection and timely intervention,\u201d said Dr. Devi Shetty, Chairman of Narayana Health<\/strong>. \u201cIt is\u00a0initiatives\u00a0like these that will help address\u00a0the growing burden of cardiovascular diseases\u00a0in the country.”<\/p>\n Padma Rhythms\u00ae ELR features dual ECG channels for precise abnormality detection, a high-resolution 16-bit ECG for accurate data analysis, and proprietary AI-powered algorithms for efficient monitoring. The device is disposable, easily activated, water-resistant, and breathable, ensuring comfort and reliable performance. Crafted with a focus on high fidelity and lightweight construction, it allows uninterrupted daily activities during continuous monitoring.<\/p>\n Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.<\/strong><\/p>\n All information provided herein is for general awareness purpose only and is not medical advice. Patients should talk to their doctor. <\/strong><\/p>\nF<\/s>ounder and Chief Executive Officer at CDL<\/strong>. \u201cThe collaboration holds immense promise for the future of cardiac care in India. The launch of Padma Rhythms\u202fmarks the coming together of\u202fa\u202fdecade of building an indigenous platform with strong R&D focus and interplay of technologies that can bring\u202fa\u202ftectonic shift\u202fin the prevailing cardiac monitoring approaches.\u201d<\/p>\n
![\"\"](\"https:\/\/cms.businesswireindia.com\/images\/pixel.gif\"){kind=tracking}
<\/p>\n